Overview

Corporate Profile
bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
Stock Quote
BLUE (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$92.00
Change (%) Stock is Up 1.02 (1.12%)
Volume1,261,611
Data as of 12/19/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
12/15/14bluebird bio Announces Pricing of Public Offering of Common StockPrinter Friendly Version
12/15/14bluebird bio Announces Proposed Public Offering of Common StockPrinter Friendly Version
12/08/14bluebird bio Announces Data Demonstrating First Four Patients with β-Thalassemia Major Treated with LentiGlobin™ are Transfusion-FreePrinter Friendly Version
11/12/14bluebird bio Reports Fiscal Third Quarter 2014 Financial ResultsPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.